What is Adaptive Biotechnologies's current debt?

Adaptive Biotechnologies (ADPT) reported current debt of $5.8M in Q1 2026.

How has Adaptive Biotechnologies's current debt changed year-over-year?

Adaptive Biotechnologies's current debt increased by 188.6% year-over-year, from $2.01M to $5.8M.

What does current debt mean?

The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.

Adaptive Biotechnologies ADPT Current Debt

Current Debt at other companies

Natera, Inc.NTRA

$80.31M0.0%

DanaherDHR

$923M+84.2%

Charles River LaboratoriesCRL

$6.7M+5,436%

RevvityRVTY

$575.83M+237,847%

Agilent TechnologiesA

$304M+108%

GeneDx HoldingsWGS

——

Other financials

Income statement

See full

Revenue$70.9M+35.1%

Gross profit$52.2M+47.1%

Operating income-$19.2M+35.1%

Net income-$20.0M+32.9%

EPS (diluted)-$0.13+35.0%

Balance sheet

See full

Cash & equivalents$77.6M+53.2%

Total debt$208.2M-5.6%

Total equity$216.3M+13.6%

Total assets$505.9M-1.0%

Cash flow

See full

Operating cash flow-$9.5M+66.5%

CapEx$796.0K-36.8%

Free cash flow-$10.3M+65.3%

Valuation

See full

Market cap$2.76B+93.6%

Enterprise value$2.89B+78.0%

P/S9.3×+1.8×

Profitability

See full

Gross margin75.3%+12.7pp

Operating margin-15.8%-7.0pp

Net margin-16.8%-7.3pp

FCF margin-10.5%-4.6pp

Returns & leverage

See full

Return on equity-24.4%-9.2pp

Debt / equity1×-0.2×

Current ratio3.4×+0.4×

Where this comes from

Reported directly by Adaptive Biotechnologies in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Adaptive Biotechnologies's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Adaptive Biotechnologies's current debt?: Adaptive Biotechnologies (ADPT) reported current debt of $5.8M in Q1 2026.
How has Adaptive Biotechnologies's current debt changed year-over-year?: Adaptive Biotechnologies's current debt increased by 188.6% year-over-year, from $2.01M to $5.8M.
What does current debt mean?: The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.